심혈관 수술용 기기 시장 : 제품 유형, 시술 유형, 최종사용자별 - 세계 예측(2025-2030년)

The Cardiovascular Surgery Devices Market was valued at USD 1.57 billion in 2023, expected to reach USD 1.65 billion in 2024, and is projected to grow at a CAGR of 5.43%, to USD 2.27 billion by 2030.

The cardiovascular surgery devices market encompasses a broad array of instruments and equipment designed for the diagnosis, treatment, and management of cardiovascular disorders. This market includes devices such as heart-lung machines, catheters, stents, and grafts, essential for surgical procedures like coronary artery bypass grafting (CABG), heart valve repair, and replacement. The necessity of these devices stems from the rising incidence of cardiovascular diseases fueled by aging populations, sedentary lifestyles, and increasing obesity rates. These devices find application in hospitals, specialized cardiac care centers, and outpatient facilities, serving a critical role in both conventional and minimally invasive surgical procedures.

Market growth is influenced by several factors, including technological advancements, growing preference for minimally invasive surgery, and extensive R&D investment by key players. Recent trends such as the integration of AI and IoT in surgical devices have unlocked potential opportunities by offering real-time data analytics and predictive outcomes, improving surgery success rates. Companies are encouraged to focus on product innovation, value-based care models, and strategic partnerships to leverage these opportunities. Conversely, limitations such as high device costs, stringent regulatory approvals, and the shortage of skilled surgeons pose challenges to market expansion. Regulatory compliance hurdles, particularly in emerging markets, can hinder swift product launches and adoption.

Opportunities for innovation and research are abundant in areas like bioresorbable vascular scaffolds, robot-assisted surgery, and hybrid cath lab operating environments where traditional and catheter-based procedures are combined. Developing solutions that enhance surgical precision and reduce recovery times can offer a competitive advantage. Additionally, the market nature is highly dynamic due to rapid technological shifts and healthcare reimbursement policies. By focusing on these innovation avenues and adapting to regulatory landscapes, businesses can position themselves strongly in this evolving ecosystem, driving sustained growth while meeting the increasing demand for efficient cardiovascular surgical solutions.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cardiovascular Surgery Devices Market

The Cardiovascular Surgery Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing incidence of cardiovascular diseases due to lifestyle and dietary changes leading to higher surgical interventions
  • Rapid technological advancements and innovation in cardiovascular surgery devices improving patient outcomes
  • Increasing aging population prone to heart conditions boosting demand for cardiovascular surgery procedures
  • Expansion of healthcare infrastructure and access to advanced medical facilities in emerging markets
• Market Restraints
  • High Cost for advance procedure and material in cardiovascular surgery
• Market Opportunities
  • Integration of artificial intelligence and machine learning in surgical device
  • Growing demand for minimally invasive cardiovascular surgery devices driven by technological advancements and aging population
• Market Challenges
  • Increased competition from alternative treatments and non-invasive cardiovascular procedures.

Porter's Five Forces: A Strategic Tool for Navigating the Cardiovascular Surgery Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cardiovascular Surgery Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cardiovascular Surgery Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cardiovascular Surgery Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cardiovascular Surgery Devices Market

A detailed market share analysis in the Cardiovascular Surgery Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cardiovascular Surgery Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cardiovascular Surgery Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cardiovascular Surgery Devices Market

A strategic analysis of the Cardiovascular Surgery Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cardiovascular Surgery Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Biotronik SE & Co. KG, Boston Scientific Corporation, Canon Medical Systems Corporation, Edwards Lifesciences Corporation, Fresenius Medical Care AG & Co. KGaA, GE HealthCare Technologies Inc., Getinge AB, Johnson & Johnson, LivaNova PLC, Maquet Cardiovascular LLC, Medtronic plc, MicroPort Scientific Corporation, Philips Healthcare, Siemens Healthineers AG, St. Jude Medical, Inc., Stryker Corporation, Terumo Corporation, W. L. Gore & Associates, Inc., and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Cardiovascular Surgery Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product Type, market is studied across Cardiopulmonary Bypass Equipment, Heart Valve Devices, and Perfusion Disposables. The Cardiopulmonary Bypass Equipment is further studied across Cannulae, Oxygenators, and Reservoirs. The Heart Valve Devices is further studied across Mechanical Heart Valves, Tissue Heart Valves, and Transcatheter Heart Valves. The Perfusion Disposables is further studied across Blood Cardioplegia.
• Based on Procedure Type, market is studied across Cardiovascular Surgery and Coronary Artery Bypass Grafting (CABG).
• Based on End User, market is studied across Cardiac Centers and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing incidence of cardiovascular diseases due to lifestyle and dietary changes leading to higher surgical interventions
    • 5.1.1.2. Rapid technological advancements and innovation in cardiovascular surgery devices improving patient outcomes
    • 5.1.1.3. Increasing aging population prone to heart conditions boosting demand for cardiovascular surgery procedures
    • 5.1.1.4. Expansion of healthcare infrastructure and access to advanced medical facilities in emerging markets
  • 5.1.2. Restraints
    • 5.1.2.1. High Cost for advance procedure and material in cardiovascular surgery
  • 5.1.3. Opportunities
    • 5.1.3.1. Integration of artificial intelligence and machine learning in surgical device
    • 5.1.3.2. Growing demand for minimally invasive cardiovascular surgery devices driven by technological advancements and aging population
  • 5.1.4. Challenges
    • 5.1.4.1. Increased competition from alternative treatments and non-invasive cardiovascular procedures.
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Cardiovascular Surgery Devices Market, by Product Type

• 6.1. Introduction
• 6.2. Cardiopulmonary Bypass Equipment
  • 6.2.1. Cannulae
  • 6.2.2. Oxygenators
  • 6.2.3. Reservoirs
• 6.3. Heart Valve Devices
  • 6.3.1. Mechanical Heart Valves
  • 6.3.2. Tissue Heart Valves
  • 6.3.3. Transcatheter Heart Valves
• 6.4. Perfusion Disposables
  • 6.4.1. Blood Cardioplegia

7. Cardiovascular Surgery Devices Market, by Procedure Type

• 7.1. Introduction
• 7.2. Cardiovascular Surgery
• 7.3. Coronary Artery Bypass Grafting (CABG)

8. Cardiovascular Surgery Devices Market, by End User

• 8.1. Introduction
• 8.2. Cardiac Centers
• 8.3. Hospitals

9. Americas Cardiovascular Surgery Devices Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Cardiovascular Surgery Devices Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Cardiovascular Surgery Devices Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Biotronik SE & Co. KG
• 3. Boston Scientific Corporation
• 4. Canon Medical Systems Corporation
• 5. Edwards Lifesciences Corporation
• 6. Fresenius Medical Care AG & Co. KGaA
• 7. GE HealthCare Technologies Inc.
• 8. Getinge AB
• 9. Johnson & Johnson
• 10. LivaNova PLC
• 11. Maquet Cardiovascular LLC
• 12. Medtronic plc
• 13. MicroPort Scientific Corporation
• 14. Philips Healthcare
• 15. Siemens Healthineers AG
• 16. St. Jude Medical, Inc.
• 17. Stryker Corporation
• 18. Terumo Corporation
• 19. W. L. Gore & Associates, Inc.
• 20. Zimmer Biomet Holdings, Inc.